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Background: VanYn, encoded by the dbv7 gene (also known as vanYn) of the biosynthetic cluster devoted to
A40926 production, is a novel protein involved in the mechanism of self-resistance in Nonomuraea sp. ATCC 39727.
This filamentous actinomycete is an uncommon microorganism, difficult-to-handle but biotechnologically valuable
since it produces the glycopeptide antibiotic A40926, which is the precursor of the second-generation dalbavancin
in phase III of clinical development. In order to investigate VanYn role in glycopeptide resistance in the producer
actinomycete an appropriate host-vector expression system is required.
Results: The cloning strategy of vanYn gene (G-C ratio 73.3%) in the expression vector pIJ86 yielded a recombinant
protein with a tag encoding for a histidine hexamer added at the C-terminus (C-His6-vanYn) or at the N-terminus
(N-His6-vanYn). These plasmids were used to transform three Streptomyces spp., which are genetically-treatable high
G-C content Gram-positive bacteria taxonomically related to the homologous producer Nonomuraea sp.. Highest
yield of protein expression and purification (12 mg of protein per liter of culture at 3 L bioreactor-scale) was
achieved in Streptomyces venezuelae ATCC 10595, that is a fast growing streptomyces susceptible to glycopeptides.
VanYn is a transmembrane protein which was easily detached and recovered from the cell wall fraction. Purified
C-His6-VanYn showed D,D-carboxypeptidase and D,D-dipeptidase activities on synthetic analogs of bacterial
peptidoglycan (PG) precursors. C-His6-VanYn over-expression conferred glycopeptide resistance to S. venezuelae.
On the contrary, the addition of His6-tag at the N-terminus of the protein abolished its biological activity either
in vitro or in vivo assays.
Conclusions: Heterologous expression of vanYn from Nonomuraea sp. ATCC 39727 in S. venezuelae was successfully
achieved and conferred the host an increased level of glycopeptide resistance. Cellular localization of recombinant
VanYn together with its enzymatic activity as a D,D-peptidase/D,D-carboxypeptidase agree with its role in removing
the last D-Ala from the pentapeptide PG precursors and reprogramming cell wall biosynthesis, as previously reported
in glycopeptide resistant pathogens.
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Filamentous actinomycetes are high G-C Gram-positive
microorganisms commercially widely used as producers
of natural products (in particular antibiotics) and indus-
trial enzymes [1]. Genome sequencing of representative
microbes belonging to this group has shown that they
possess a vast array of genes devoted to the production
and secretion of enzymes, due to the role they play in re-
cycling organic material in the biosphere [2]. Genome
annotation of Streptomyces coelicolor [3], which is the
model system for this microbial group, revealed that it
encodes 819 potentially secreted proteins including hy-
drolases, proteases/peptidases, chitinases/chitosanases,
cellulases/endoglucanases, amylases and pectate lyases.
Moreover, filamentous actinomycetes are rich of novel
enzymatic functionalities since each genome hosts
twenty-thirty biosynthetic gene clusters (20–100 kbp
each) devoted to the production of chemically diverse
bioactive metabolites [1]. Among filamentous actinomy-
cetes, the most studied genus is the Streptomyces one,
whose members produce two-thirds of the known anti-
biotics [4]. Streptomyces spp. are also used as host sys-
tems for the production of heterologous proteins and
of whole biosynthetic clusters originating from less
easy-to-handle actinomycetes, such as those belonging to
Nonomuraea, Actinoplanes, Planomonospora, Planobis-
pora, Microbispora genera [1]. These uncommon actino-
mycetes possess a still-untapped richness of metabolic
pathways - and some of them are valuable producers of
new drugs - but their exploitation is often limited by the
lack of genetic manipulation tools [5,6].
Streptomyces spp. as heterologous hosts for gene ex-
pression and protein production offer some advantages
in comparison to Escherichia coli, the preferred cell fac-
tory for industrial enzymes and therapeutic proteins
[7,8]. Production and isolation of heterologous proteins
from E. coli is often limited by insolubility, citotoxicity,
uncorrect folding, aggregation in inclusion bodies and
lack of secretion [2]. Secretion capability of Streptomyces
spp. may prevent the local accumulation of the over-
expressed recombinant proteins, reduce their toxicity to
host cells, eventually aid correct folding and favour in-
creased production and purification yields [9]. Heterol-
ogous expression is often facilitated when the selected
host cells are phylogeneticaly related to the homologous
producer. This is due to the similarity of codon usage,
compatibility with translation machinery, molecular
chaperons, and/or redox state of the cells [2].
We recently started studying the role of genes in-
volved in the biosynthesis, regulation, transport and
self-resistance of glycopeptide antibiotics in producing
strains which belong to uncommon actinomycetes such as
Actinoplanes teichomyceticus producing teicoplanin [10,11]
and Nonomuraea sp. ATCC 39727, which producesA40926 [12]. A40926 is the precursor of the semi-synthetic
derivative dalbavancin, which is a second generation glyco-
peptide currently in phase III clinical development for its
improved activity, pharmacokinetics and pharmacodynam-
ics [13]. The dbv cluster, which is a contiguous set of 37
ORFs devoted to the production, regulation and transport
of A40926, contains the vanYn gene, whose function was
proposed to confer glycopeptide resistance to the produ-
cing strain by reprogramming peptidoglycan cell wall bio-
synthesis [12,13].
The aim of this work was developing an appropriate
heterologous expression system for VanYn characterization
to help deciphering its role in glycopeptide resistant cells.
Our attention was given to screening different Streptomy-
ces spp. as hosts for recombinant VanYn secretion in
biologically active form. Conditions for production (and
purification) of functional VanYn were finally successfully
settled in Streptomyces venezuelae ATCC 10595 at flask
and at fermentor-scale.
Results
Heterologous expression of VanYn in Streptomyces spp.
vanYn encoding gene (CAD91202) was amplified by PCR
using chromosomal DNA template from Nonomuraea sp.
ATCC 39727 [12] and cloned in the multicopy vector
pIJ86, under the control of the heterologous constitutive
promoter ermE* [14]. The gene was cloned in frame
with a sequence encoding for a histidine hexamer added
at the C-terminus (C-His6-vanYn) or at the N-terminus
(N-His6-vanYn) of the protein product.
pIJ86ΩC-His6-vanYn, pIJ86ΩN-His6-vanYn, and the
empty pIJ86 used as a control, were introduced in three
different Streptomyces spp. by intergeneric conjugation
from E. coli. Streptomyces lividans TK24 was selected
as one of the hosts since it is used for heterologous
protein production due to its proven excellence in se-
cretion capacity and low extracellular protease activity
[15]. Streptomyces venezuelae ATCC 10595 is a fast
growing streptomyces naturally susceptible to glycopep-
tides [12]. Streptomyces coelicolor A3(2) represents the
model system [3] and possesses a complete set of
vanRSHAX genes conferring high resistance to vanco-
mycin: consequently a glycopeptide susceptible mutant
deleted in the two component regulatory system ΔvanRS
was used in our experiments [16].
Growth curves at shake flask-scale of the ex-conjugants
S. coelicolor ΔvanRS, S. lividans and S. venezuelae carrying
pIJ86ΩC-His6-vanYn or pIJ86ΩN-His6-vanYn were com-
pared with control strains containing the empty vector in
two different cultivation conditions, i.e. by using the limpid
YEME medium or the rich and complex BTSB medium
(Figure 1 and Table 1). Figure 1A and 1B show the growth
curves of S. venezuelae recombinant strains, which pro-
duced abundant biomass in both the media. Introduction
Figure 1 Growth of S. venezuelae pIJ86ΩC-His6-vanYn, S. venezuelae pIJ86ΩN-His6-vanYn and S. venezuelae pIJ86 in YEME (A) and in
BTSB (B) at flask level. S. venezuelae pIJ86ΩC-His6-vanYn dry weight (■ , solid line) and glucose consumption (□, dashed line); S. venezuelae
pIJ86ΩN-His6-vanYn dry weight (● , solid line) and glucose consumption (○, dashed line); S. venezuelae pIJ86 dry weight (♦, solid line) and glucose
consumption (◊, dashed line). In (C), morphology of S. venezuelae pIJ86 (1), S. venezuelae pIJ86ΩN-His6-vanYn (2) and S. venezuelae pIJ86ΩC-His6-vanYn
(3) grown in YEME for 72 hours at the optical microscopic observation (Zeiss Primo Star phase-contrast microscopy with 40X enlargement).
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kinetics was similar among S. venezuelae carrying either
C-His6-vanYn or N-His6-vanYn constructs and the con-
trol strain. Maximum biomass production (≥ 30 g/L dry
weight) was achieved after 72 hours from the inoculum
in both YEME and BTSB media. Glucose was consumed
with different kinetics between the two media, but it was
anyhow completely depleted within 72 hours of growth.
Observation at the optical microscope showed that myce-
lium in recombinant strains was more fragmented than in
the control one (Figure 1C).
Data in Table 1 shows that S. coelicolor ΔvanRS recom-
binant strains grew better in BTSB than in YEME,
whereas recombinant S. lividans strains did not grow in
YEME medium. Different effects of medium composition
on growth rate and morphology of suspension cultures(i.e. size of mycelium pellets) among diverse streptomy-
ces hosts have been previously observed [14]. Production
of His6-VanYn was evaluated by Western blot analysis
after 72 hours of growth in S. venezuelae, S. coelicolor
ΔvanRS and S. lividans recombinant strains. In BTSB
medium, recombinant VanYn volumetric and specific
productivities ranged between 18 to more than 30 mg
per liter of culture and from 0.8 to more than 1 mg per
gram of cells, within the different recombinant strains. In
YEME medium, the highest values of volumetric (about
30 mg of VanYn per liter of culture) and specific (slightly
less than 1 mg of enzyme per gram of cells) productiv-
ities were achieved only for S. venezuelae recombinant
strains. Considering that BTSB medium contains com-
plex components which may later on interfere with
protein purification, YEME medium was preferred for
Table 1 Biomass and VanYn production in recombinant Streptomyces spp.
Strain Vector Medium Dry weight (g cell/L) VanYn (mg/g cell) VanYn (mg/L)
S. venezuelae pIJ86ΩC-His6-vanYn BTSB 30 0.94 28.4
S. venezuelae pIJ86ΩC-His6-vanYn YEME 30 0.97 30.7
S. venezuelae pIJ86ΩN-His6-vanYn BTSB 36 1.47 23.9
S. venezuelae pIJ86ΩN-His6-vanYn YEME 35 1.10 31.6
S. coelicolor ΔvanRS pIJ86ΩC-His6-vanYn BTSB 25 1.16 28.9
S. coelicolor ΔvanRS pIJ86ΩC-His6-vanYn YEME 20 0.62 12.4
S. coelicolor ΔvanRS pIJ86ΩN-His6-vanYn BTSB 30 1.06 31.8
S. coelicolor ΔvanRS pIJ86ΩN-His6-vanYn YEME 8 0.79 6.3
S. lividans pIJ86ΩC-His6-vanYn BTSB 20 1.02 20.3
S. lividans pIJ86ΩN-His6-vanYn BTSB 22 0.80 18
Streptomyces spp. recombinant strains carrying different constructs (C-His6-vanYn or N-His6-vanYn) were grown in YEME or BTSB for 72 hours. VanYn was quantified
by immunoblotting on crude extracts as reported in the Methods.
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was selected as the preferable host for protein production
scaling-up and purification.
Cellular localization of His6-VanYn was analyzed after
72 hours of growth in S. venezuelae, S. coelicolor ΔvanRSFigure 2 Western blot analysis of C-His6-VanYn and N-His6-VanYn from
corresponding to cellular and extracellular fractions from cultures of S. vene
S. venezuelae pIJ86ΩN-His6-vanYn: extracellular fraction (lane 1), soluble cell-
fraction (lane 4); from S. venezuelae pIJ86ΩC-His6-vanYn: extracellular fractio
(lane 7) and cell wall fraction (lane 8). A crude extract from S. venezuelae ce
In each lane, samples corresponding to 100 μL of cell culture were loaded.
corresponding SDS-PAGE is shown in the Additional file 1: Figure S1. (B): q
performed using the Quantity One program (Bio-Rad Laboratories, Milan, It
each fraction was determined by Biuret method (□, solid line).and S. lividans recombinant strains by Western blot ana-
lysis on different fractions (prepared as described in the
Methods section). Figure 2A shows a ~ 25 kDa band cor-
responding to His6-VanYn (predicted molecular mass of
native VanYn is 22.1 kDa) in the insoluble and solubleS. venezuelae recombinant strains. (A): analysis of samples
zuelae recombinant strains grown in YEME for 72 hours. From
free fraction (lane 2), insoluble cell-free fraction (lane 3) and cell wall
n (lane 5), soluble cell-free fraction (lane 6), insoluble cell-free fraction
lls carrying the empty vector was loaded as a negative control (CTRL).
Std reference protein: C-His6-VanYn from E. coli (5 μg, 25 kDa). The
uantitative analysis of recombinant VanYn present in each fraction,
aly) and His6-VanYn as comparative standard. Total protein content in
Figure 3 Growth curve and VanYn production in 3-L batch
fermentations of S. venezuelae pIJ86ΩC-His6-vanYn in YEME.
(A) Time courses of pH (□, dashed line), pO2 (●, solid line), glucose
(○, dashed line), and growth curve measured as dry weight (♦, solid
line). (B) Time course of recombinant VanYn production as
determined by quantitative Western blot analysis of crude extracts
from cell samples collected at different times of fermentation (see
panel C). Maximum protein expression at 48 hours of growth was set
as 100% (corresponding to ~ 30 mg/L of culture). Total protein
content in each fermentation sample was determined by Biuret
method (● , solid line). In (C), samples corresponding to 100 μL of
cell culture were loaded in each lane; Std, standard reference protein:
C-His6-VanYn from E. coli (5 μg, 25 kDa). The corresponding SDS-PAGE
is shown in the Additional file 2: Figure S2.
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S. venezuelae recombinant strains grown in YEME
medium. Recombinant VanYn was never found in the
concentrated broths (extracellular fractions, lanes 1 and
5 of Figure 2A). Densitometric analysis demonstrated
that His6-VanYn preferentially accumulated (90%, lanes 4
and 8 of Figure 2B) in the cell wall fractions obtained by
the step of spheroplast preparation, independently on
the localization of the His6-tag (at the C-terminus or at
the N-terminus of the protein). Only 6% and 4% of re-
combinant protein was detected in insoluble and soluble
cell-free fractions following spheroplast burst, respect-
ively. For all recombinant strains grown in BTSB or
YEME (Table 1), the heterologous protein distribution
was exactly as for S. venezuelae, with most of VanYn re-
covered from the cell wall fraction (data not shown).
VanYn production by S. venezuelae in 3 L bench-bioreactor
scale
Both the forms of recombinant His6-VanYn were produced
growing S. venezuelae recombinant strains in YEME
medium at 3 L bench-bioreactor scale. Figures 3A, B and
C show the time course of growth and VanYn production
of S. venezuelae carrying pIJ86ΩC-His6-vanYn. Exponential
growth was actually completed within 48 hours and gave a
maximum biomass yield of 40 g/L dry weight. This growth
phase was accompanied by a complete depletion of glucose
from the medium and by a transient reduction of dissolved
oxygen (pO2). Medium pH slightly decreased during the
exponential growth phase and then tended to increase
during the stationary growth phase. An estimated max-
imum of production of ~ 30 mg VanYn/L in the crude ex-
tract was determined at the peak of biomass production,
i.e. at 48 hours from inoculum. An overlapping profile of
growth curve and VanYn production was similarly
obtained for S. venezuelae carrying pIJ86ΩN-His6-vanYn
(not shown).
VanYn purification from S. venezuelae
Purification of both the recombinant forms of His6-
VanYn from S. venezuelae cells grown in YEME medium,
was attempted by means of metal-chelating chromatog-
raphy on HiTrap chelating column of crude extracts
obtained by whole cell sonication, as described in the
Methods section. N-His6-VanYn was eluted following
standard procedures. In the same conditions, C-His6-
VanYn did not bind to the column, suggesting that the
six histidines at C-terminus were masked. Accordingly, a
denaturing agent such as urea was added to both the
loading and equilibration buffers. The partially dena-
tured C-His6-VanYn protein interacted with the matrix
and was subsequently re-folded directly on the column
by a linear gradient of decreasing urea concentration.
SDS-PAGE analysis (Figure 4) confirmed that both thetagged forms of His6-VanYn migrated as a single band of
25 kDa and were > 90% pure. Final purification yield was
comparable between the two forms: approximately
12 mg of C- or N-His6-VanYn protein from one liter of
culture were recovered.
Figure 4 Purification of recombinant VanYn. SDS-PAGE Analysis
(staining with Coomassie brilliant blue) of protein samples collected
during purification of VanYn from S. venezuelae carrying pIJ86ΩN-
His6-vanYn or pIJ86ΩC-His6-vanYn. Crude fractions from S. venezuelae
carrying pIJ86ΩN-His6-vanYn (lane 1) and S. venezuelae carrying
pIJ86ΩC-His6-vanYn (lane 2). Fractions from HiTrap Chelating
chromatography: N-His6-VanYn flow through (lane 3), C-His6-VanYn
flow through at 6 M (lane 4), 4 M (lane 5) and 1 M (lane 6) urea.
Purified N-His6-VanYn (lane 7, 2 μg) and C-His6-VanYn (lane 8, 4 μg)
after desalting gel permeation. The purified VanYn migrated as a
single band at a molecular mass of ~ 25 kDa and with > 90% purity.
Standard reference protein: C-His6-VanYn from E. coli BL21(DE3) Star
(5 μg, 25 kDa). LMW, molecular mass standard proteins
(Amersham, GE-Healthcare).
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Activities of purified C-His6-VanYn and N-His6-VanYn
from S. venezuelae recombinant strains were assayed
on commercially available surrogates of peptidoglycan
precursors, in parallel with the previously characterized
C-His6-VanYn produced by recombinant E. coli [17].
These results were obtained by the D-amino acid oxidase/
peroxidase colorimetric coupled reaction [18,19], and con-
firmed by a fluorimetric assay [20]. As shown in Table 2,
C-His6-VanYn from S. venezuelae cleaved the last D-AlaTable 2 Substrate specificity of His6-VanYn recombinant
forms produced by different hosts







D-Ala-D-Ala 18 ± 5.0 0 19 ± 3
Nα,Nε-diacetyl-L-Lys-D-
Ala-D-Ala
38 ± 3.8 0 36 ± 4.0
Acetyl-L-Lys-D-Ala-D-Ala 40 ± 5.6 0 40 ± 3.0
Specific activity (U/mg protein) was determined using 40 μg of His6-VanYn
added to 10 mM solutions of the indicated compounds. The activity was
assayed at 25°C as described in the Methods section. Results are the average
of three independent experiments.from the tripeptide Nα,Nε-diacetyl-L-Lys-D-Ala-D-Ala and
acetyl-L-Lys-D-Ala-D-Ala, this activity being only slightly
affected by the acetylation grade of the Lys. The activity
was halved if the substrate was the D-Ala-D-Ala. Thus,
C-His6-VanYn showed a higher D,D-carboxypeptidase ac-
tivity (VanY-like) than a D,D-peptidase activity (VanX-like).
Surprisingly, N-His6-VanYn from S. venezuelae did not
show any activity on the three substrates (Table 2),
suggesting that the tag position dramatically influenced en-
zyme competence.
These results were supported by the circular dichroism
(CD) spectra of the recombinant proteins. CD spectrum
of C-His6-VanYn produced in S. venezuelae overlapped
with that of the protein produced in E. coli (Figure 5):
analysis of secondary structure indicates a predominance
of β-sheets (~ 38%) and ~ 15% of α-helices. This struc-
ture content was altered for the N-His6-VanYn (Figure 5),
indicating that N-terminal tag interfered with the proper
protein folding and secondary structure content of the
recombinant enzyme.Resistance phenotype in S. venezuelae recombinant strains
Role of different constructs of vanYn, when over-expressed
in a glycopeptide-susceptible heterologous host such
as S. venezuelae, was investigated in vivo by determin-
ing the D,D-peptidase/D,D-carboxypeptidase activity of
alkaline cell extracts and the glycopeptide resistance
phenotype of recombinant strains. As shown in Table 3,
D,D-peptidase/D,D-carboxypeptidase activity was de-
tectable only in S. venezuelae pIJ86ΩC-His6-vanYn and
S. venezuelae pIJ86ΩvanYn (a strain with vanYn clonedFigure 5 Far-UV CD spectra of recombinant VanYn. C-His6-VanYn
(dotted line) and N-His6-VanYn (dashed line) from recombinant
S. venezuelae (S. v.); C-His6-VanYn from recombinant E. coli (E. c.)
(continuous line). Protein concentration was 0.1 mg/mL, 15°C.
Table 3 Resistance and enzyme activity profiles of S. venezuelae strains
MIC Enzyme activity
Strain Vancomycin (μg/mL) Teicoplanin (μg/mL) D,D-carboxypeptidase (U/mg) D,D-peptidase (U/mg)
wild-type 0.2 0.5 0 0
pIJ86 0.2 0.5 0 0
pIJ86ΩC-His6-vanYn 0.4 0.7 189 ± 5.5 100 ± 3.9
pIJ86ΩN-His6-vanYn 0.2 0.5 0 0
pIJ86ΩvanYn 0.4 0.7 172 ± 4.3 80 ± 3.2
MICs of glycopeptides were determined by plating 106 cfu/mL of each strain on agar medium added with different antibiotic concentrations. Results are the
average of three independent experiments in which the standard deviation was less than 5%. Specific activity (U/mg protein) was determined in alkaline cell
extracts added to 10 mM solutions of acetyl-L-Lys-D-Ala-D-Ala or D-Ala-D-Ala. The activity was assayed at 25°C as described in the Methods section [17]. Results
are the average of three independent experiments.
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pIJ86ΩN-His6-vanYn neither in S. venezualae wild-
type or in S. venezualae containing the empty vector.
Table 3 also reports the minimal inhibitory concen-
trations (MICs) of vancomycin and teicoplanin to the
recombinant strains in comparison with the wild-type.
Accordingly to the expression of the D,D-peptidase/D,
D-carboxypeptidase activity, S. venezuelae expressing
C-His6-VanYn and S. venezuelae producing VanYn
without any tag showed an increased resistance level
against both glycopeptides. Resistance phenotype of
S. venezuelae producing the N-His6-VanYn was the
same as in the control strain with empty vector or in
the wild-type.
These data confirm the role of VanYn in conferring
glycopeptide resistance to a susceptible host and indicate
that C-terminal His6-VanYn behaved in vivo as the native
VanYn, whereas the addition of His6 at the N-terminus
of the protein abolished its biological activity.
Discussion
C-His6-VanYn was previously produced in BL21(DE3)
Star E. coli cells as a cytoplasmatic soluble protein
[13]. In that case, codon usage optimization of the syn-
thetic gene was essential since E. coli is a low G-C ratio
(~ 50%) Gram-negative bacterium whereas Nonomuraea
sp. is a high G-C Gram-positive actinomycete. The G-C
ratio of vanYn is 73.3% which is similar to the gen-
omic ratio of the reference S. coelicolor A3(2) (72%)
and S. venezuelae ETH14630 (71%) [14]. The G-C ra-
tio of the dbv cluster is 70.4%. Notwithstanding our ef-
forts in optimizing cultivation, induction and purification
conditions, the best productivity achieved in recombin-
ant E. coli was 4.6 mg/L culture (0.13 mg/g cells) [17].
Similar level of expression was obtained by other authors
who cloned vanXYC from Enterococcus gallinarum
BM4174 in E. coli JM83 [21], vanX from Enterococcus
faecium BM4147 in E. coli W3110 [22] and vanY from
Enterococcus faecium BM4147 in E. coli JM83 [20].
VanXYC, VanX and VanY are D,D-carboxypeptidases/D,
D-peptidases homologous to VanYn involved in conferringglycopeptide resistance to enterococci, which are Gram-
positive pathogens with low G-C content [23,24].
By cloning vanYn from Nonomuraea sp. ATCC 39727
in the taxonomically closely related S. venezuelae, pure
protein production was at least three folds higher
(12 mg/L culture) than in E. coli. Since estimated volu-
metric productivity in the harvested cells was around
30 mg of protein per liter of culture, there is still room
to improve the final yield by further optimization of the
purification procedure. Estimated specific productivity of
around 1 mg VanYn per gram of cells in streptomycetes
was much higher than the one achieved in E. coli
(0.13 mg/g cells) confirming that streptomycetes are
preferable hosts for VanYn production. Comparable bio-
mass and protein production were achieved at flask and
at 3 L bioreactor-scale: maximum values being one day
anticipated in bioreactor runs. Fermentation and down-
stream technologies are well developed for streptomy-
cetes, which are industrially relevant microorganisms
producing many valuable antibiotics and other bioactive
metabolites [1]; thus they can be successfully further ap-
plied to improving and scaling-up VanYn production.
An important difference between heterologous pro-
duction of VanYn in recombinant streptomycetes and
E. coli is the preferential subcellular localization of the
protein. VanYn (196 amino acids) contains three differ-
ent putative domains: a cytoplasmatic domain at the
N-terminus (the first 20 amino acids), an hydrophobic
trans-membrane portion (20 amino acids), followed by
the C-terminal domain exposed on the external face of
cytoplasmatic membrane. This extracellular domain
contains conserved motifs (SxHxxGxAxD and ExxH)
for the coordination of zinc ions and the catalytic active
site [23,25,26]. In E. coli recombinant cells, C-His6-
tagged-VanYn was accumulated in the cytoplasm,
whereas in streptomycetes the most (90%) of the tagged
enzyme was recovered from the cell wall fraction. The
localization of VanYn confirms its role in the extracellu-
lar phases of cell wall biosynthesis [23,25]. The addition
of detergents did not improve purification from the
whole cell extract, confirming that the protein is easily
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from glycopeptide resistant enterococci are in fact in-
volved in the extracytoplasmatic hydrolysis of the last
D-Ala from the UDP-pentapeptide PG precursors [20].
The enzymatic activity and the spectral investiga-
tion (by CD spectroscopy) confirmed the identity of
C-His6-VanYn produced by recombinant cells of either
S. venezuelae or E. coli. On substrates that mimic peptido-
glycan precursors, VanYn showed D,D-carboxypeptidase
and D,D-dipeptidase activity, resembling more VanXYC
from VanC-type Enterococcus gallinarum [21] than typical
VanY D,D-carboxypeptidases and VanX D,D-peptidases
firstly characterized in Enterococcus faecium BM4147
[20,27,28]. On the other hand, the introduction of an
histidine hexamer at the N-terminus of VanYn abolishes
the enzymatic activity and alters protein secondary struc-
ture, suggesting that it interferes with the folding of the
active protein. Till now, VanY family of D,D-carboxypep-
tidases have not been structurally investigated. The pos-
sibility to produce discrete amounts of pure VanYn by
using S. venezuelae as a cell factory open the way to
better investigate the peculiar bifunctional activity of this
D,D-dipeptidase/D,D-carboxypeptidase and its interaction
with substrates and inhibitors.
Finally, the functional study of recombinant VanYn
activity in cellular extracts confirmed the role of this
protein in conferring glycopeptide resistance in a sus-
ceptible host such as S. venezuelae, which lacks those
vanRSHAX genes commonly considered essential to
confer glycopeptide resistance [24]. Our data show that
when vanYn gene was produced in the biologically active
form (C-His6-VanYn or VanYn without any tag), its
expression conferred resistance in the absence of
vanRSHAX genes, albeit at a reduced level, as previously
demonstrated in the homologous producer Nonomuraea
sp. ATCC 39727 [12]. As proof of this, expression of the
inactive N-His6-VanYn form did not increase the level of
resistance towards two glycopeptides (vancomycin and
teicoplanin) of the recombinant hosts, which remains the
same as in the wild-type and as in the control recombin-
ant strain containing only the empty vector.
Conclusions
Streptomyces spp. were demonstrated valuable hosts for
the production of specific peptidases, involved in cell
wall turnover of glycopeptide resistant microbial cells.
The novel D,D-dipeptidase/D,D-carboxypeptidase VanYn
from the glycopeptide producer Nonomuraea sp. ATCC
39727 was successfully produced in a good yield and
in the biologically active form conferring resistance to
the glycopeptide susceptible S. venezuelae strain. De-
veloping such streptomyces cell factory system for
VanYn production opens the way to a further charac-




Nonomuraea sp. ATCC 39727 was maintained and
cultivated to prepare genomic DNA according to [12].
Streptomyces coelicolor ΔvanRS was gently donated by
Hee-Jeon Hong, University of Cambridge, UK [16],
Streptomyces lividans TK24 and Streptomyces vene-
zuelae ATCC 10595 were a gift from Mervyn Bibb,
John Innes Institute, Norwich, UK [14]. Streptomyces
spp. strains were maintained as spores in 10% (v/v)
glycerol and propagated in MYM and SFM agar media
[14]. For growing ex-conjugants containing pIJ86,
pIJ86ΩC-His6-vanYn, pIJ86ΩN-vanYn and pIJ86ΩvanYn,
agar plates were added with 50 μg/mL of apramycin
(Sigma-Aldrich, Milan, Italy). Agar plates were incubated
at 28°C. Liquid media for streptomycetes were YEME -
containing in (w/v) 0.3% yeast extract, 0.5% bacto-peptone,
0.3% oxoid malt extract, 1% glucose in deionized water,
pH 7.0- and BTSB -containing in (w/v) 10% sucrose, 1%
yeast extract, 1% glucose, 0.5% NaCl, 0.5% soybean meal,
1.7% tryptone and 0.25% K2HPO4 in deionized water,
pH 7.0. All medium components were from Sigma-Aldrich
(Milan, Italy), unless otherwise stated. Colonies were
picked up from agar plates and inoculated into 300 mL
baffled flasks containing 50 mL of YEME or BTSB. Flask
cultures were incubated on a rotary shaker at 200 rpm and
28°C. Media and culture conditions for E. coli were de-
scribed in [12]. E. coli DH5α was used as host for plasmid
construction. Escherichia coli ET12567/pUZ8002 [5] was
used as non-methylating plasmid donor strain for intergen-
eric conjugation with Streptomyces spp. Cells were propa-
gated in Luria-Bertani (LB) (Sigma-Aldrich, Milan, Italy)
broth at 37°C.
Plasmids
pIJ86 (gift from Mervyn Bibb) was used as a multi-
copy vector for heterologous expression in Strepto-
myces spp. [12]. Plasmids pIJ86ΩC-His6-vanYn and
pIJ86ΩN-His6-vanYn were constructed as follow. Ex-
pand High Fidelity polymerase (Roche, Milan, Italy)
was used to amplify vanYn using genomic DNA of
Nonomuraea sp. ATCC 39727 as template with oligo-
nucleotide primers vanY004Fw (50-ATAGGATCCCCA
GACTGGAGGAGAGGGATGAGGAGAAGCGAGGG
TGAC-30) and vanY004Rev (50-GATAAGCTTCTAG
TGGTGGTGGTGGTGGTGGACCCGGCCCCCGTTC
CGGCT-30) that introduced a C-terminal tag of six his-
tidine residues and the HindIII and BamHI (Roche,
Milan, Italy) restriction sites, respectively, into the PCR
product, allowing insertion into the multiple cloning
site of the multicopy expression vector pIJ86. The
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duced using as oligonucleotide primers vanY003Fw (50-
ATATTTGGATCCATGCACCACCACCACCACCACAG
GAGAAGCGAGGGTGACGAC-30) and vanY003Rev (50-
GATAAGCTTCCCGTGCCCTAGCTAGACCCGGCCCC
CGTTCCGGCT-30) that introduced HindIII and BamHI
restriction sites. The vanYn without any tag was pro-
duced using as oligonucleotide primers vanY86Fw
(50-ATGGATCCCAGACTGGAGGAGAGGGATG-30) and
vanY86Rev (50-GATAAGCTTCGATCCTGGAGTTCGTC
TTC-30) that introduced BamHI and HindIII restriction
sites [12]. The PCR products were purified, digested with
HindIII and BamHI, and ligated with pIJ86 vector that had
similarly been digested, to produce pIJ86ΩC-His6-vanYn,
pIJ86ΩN-His6-vanYn and pIJ86ΩvanYn. These vectors
with vanYn transcribed from the strong constitutive
ermE* promoter [14] were used to transform E. coli
ET12567/pUZ8002 cells.
Intergeneric conjugation
Intergeneric conjugation was performed according to a
modified protocol from [5,14]. In brief, a culture of the
donor E. coli ET12567/pUZ8002 containing the selected
plasmid was grown in 10 mL LB supplemented with
50 μg/mL apramycin, 25 μg/mL chloramphenicol (Sigma-
Aldrich, Milan, Italy) and 50 μg/mL kanamycin (Sigma-
Aldrich, Milan, Italy) to an OD600nm of 0.4. Cells were
collected by centrifugation, washed twice with an equal
volume of LB, and resuspended in 1 mL of LB. For each
conjugation approximately 108 Streptomyces spp. spores,
collected from agar plates in sterile glycerol, were added
to 500 μL 2X YT broth [14], heat shocked at 50°C for
10 minutes and then allowed to cool. 500 μL of E. coli
cells were added to 500 μL of heat-shocked spores
and mixed briefly. Mixture was plated out on SFM or
MYM agar added with 10 mM MgCl2 and incubated
for 20 hours at 30°C. Plates were overlaid with 1 mL
of water containing 500 μg/mL nalidixic acid (Sigma-
Aldrich, Milan, Italy) and 50 μg/mL apramycin and
were incubated at 30°C until colonies appear.
Colony PCR and sequencing
The presence of pIJ86ΩvanYn, pIJ86ΩC-His6-vanYn or
pIJ86ΩN-His6-vanYn was checked by colony PCR and
DNA sequencing of ex-conjugants. Single colonies were
transferred onto DNA medium [14]. Plates were incu-
bated at 30°C overnight. Mycelium was scraped from the
plates using a sterile toothpick and was introduced into
50 μL 100% v/v DMSO in a 1.5 mL tube. The tube was
shaken vigorously for 1–2 hours and then centrifuged:
2.5 μL of the supernatant were used for PCR. For control,
1 μL of DNA samples were mixed with 1.5 μL DMSO.
One initial step of 10 minutes at 95°C was included in
the PCR program to ensure the complete cell lysis. ThePCR was performed for 30 cycles as follows: 95°C for
45 seconds, 56°C for 30 seconds and 72°C for 1 minute.
vanY004Fw, vanY004Rev, vanY003Fw and vanY003Rev,
vanY86Fw and vanY86Rev were used as oligonucleo-
tide primers.
VanYn expression
Recombinant Streptomyces spp. were grown aerobic-
ally in 100 mL YEME and BTSB media added with
apramycin (50 μg/mL) in 500 mL Erlenmayer flasks
for different time intervals (up to 196 h) at 28°C and
200 rpm. Cells were collected by centrifugation at
39000 × g for 15 minutes and washed three times
with water. The supernatant (named “extracellular
fraction”) was collected and precipitated with the
trichloroacetic acid (TCA) method. TCA precipitation
was performed adding 1/10 (v/v) of 100% TCA (w/v)
to an appropriate medium volume and vortexed for
15 seconds, placed on ice for 15 minutes and then
centrifugated at 14,000 × g for 10 minutes. The super-
natant was removed and discarded. The pellet was
washed twice with 100 μL of pure acetone and then
air dried for about 60 minutes.
Washed cells were suspended in 10 mL of 0.1 M Tris–
HCl buffer (pH 7.6) containing 0.4 M sucrose and
6.7 mg of lysozyme (Sigma-Aldrich, Milan, Italy). After
6 hours of incubation at 37°C, the mixture was
centrifuged at 12800 × g for 10 minutes, obtaining sphe-
roplasts clearly distinguishable at the optical microscopic
observation (40X, Zeiss Primo Star microscope, Arese,
Italy). The supernatant thus obtained was named “cell
wall fraction”. The spheroplasts were washed with 0.4 M
sucrose and then 5 mL of water was added to burst the
spheroplasts. The suspension was centrifuged at 2000 × g
for 30 minutes. The supernatant and the precipitate
were named as “cell-free soluble extract” and “cell-free
insoluble fraction”, respectively.
Scale up in 3-L reactor
Flask cultures of recombinant Streptomyces spp. grown
in YEME and apramycin (50 μg/mL) for 48–72 hours
were used to inoculate - at 2.5% (v/v) - 3-L P-100
Applikon glass reactor (height 25 cm, diameter 13 cm)
equipped with a AD1030 Biocontroller and AD1032
motor, containing 2 L YEME and apramycin (50 μg/mL).
Cultivations in fermenter were carried out for 168 hours
at 28°C, with stirring at 500 rpm (corresponding to
1.17 m/s of tip speed) and 2 L/min aeration rate.
Dissolved oxygen (measured as % of the initial pO2
value) was monitored using an Ingold polarographic
oxygen electrode. The pH values of culture broths were
monitored using a pH meter. Foam production was con-
trolled by adding Antifoam SE-15 (Sigma-Aldrich,
Milan, Italy) through an antifoam sensor.
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For protein purification, cultures of recombinant S. vene-
zuelae grown in YEME medium were harvested and
centrifuged at 39000 × g for 15 min at 4°C. Cells were
sonicated in a buffer solution 300 mM NaCl, 30 mM
imidazole, 10 μg/mL DNAseI (Sigma-Aldrich, Milan,
Italy), 0.19 mg/mL PMSF (Sigma-Aldrich, Milan, Italy)
and 0.7 μg/mL pepstatine (Sigma-Aldrich, Milan, Italy)
in 50 mM potassium phosphate buffer (pH 7.0), for
15 cycles of 30 seconds each on ice. After a centrifu-
gation at 39000 × g for 60 min at 4°C, the supernatant
was collected. N-His6-VanYn was purified by affinity
chromatography onto a HiTrap chelating affinity col-
umn (1.6 × 2.5 cm, 5 mL, GE Healthcare Sciences,
Milan, Italy) equilibrated with 50 mM potassium phos-
phate buffer (pH 7.0) containing 30 mM imidazole and
300 mM NaCl, according to the manufacturer’s in-
structions. After extensive washing, the bound protein
was eluted with 50 mM potassium phosphate buffer
(pH 7.0) containing 300 mM NaCl and 300 mM imid-
azole [17]. For C-His6-tagged VanYn, 6 M urea was
added to the equilibration buffer as denaturant; in
order to refold the protein bound to the column, a
linear gradient from 6 to 0 M of urea (2 mL/min) was
performed before starting the elution phase [29]. Frac-
tions containing pure recombinant VanYn were loaded
on PD10 Sephadex G25 column (Ge Healthcare Sci-
ences, Milan, Italy) equilibrated with 50 mM potassium
phosphate buffer (pH 7.0). Protein purity was checked
by SDS-PAGE (using 15% polyacrylamide gels and stain-
ing with Coomassie brilliant blue) and Western blot ana-
lysis. Protein concentration was estimated using the
extinction coefficient at 280 nm (45258 M-1 cm-1) deter-
mined by urea denaturation and the theoretical extinc-
tion coefficient based on amino acid sequence.
Western blot analysis
Following electrophoresis of proteins from bacterial cell
fractions (corresponding to 100 μL of culture) or
affinity-purified fractions and the transfer to a nitrocellu-
lose sheet (GE Healthcare Sciences, Milan, Italy), the
membrane was incubated with 1:1000 (v/v) His•TagW
Antibody HRP Conjugate Kit (Novagen, Milan, Italy) in
alkalin-casein solution 1% (v/v). The immunorecognition
was visualized by ECL Detection Reagents (GE Healthcare
Sciences, Milan, Italy). The quantitative analysis was
performed using the bioinformatics program Quantity
One (Bio-Rad Laboratories, Milan, Italy) and C-His6-
VanYn from E. coli as standard protein. For molecular
mass determination, PageRuler™ Prestained Protein Lad-
der (Thermo Scientific, Milan, Italy) markers were used.
Protein content in each fraction was assayed by Biuret
method and SDS-PAGE analysis (Additional file 1: Figure
S1 and Additional file 2: Figure S2).Alkaline extraction of D,D-carboxypeptidase
All manipulations were carried out at 0 to 4°C. Cells at
different growth phases were harvested and suspended
in 2 ml per gram of cells of physiological solution (0.9%
(v/v) NaCl). The mycelium was fragmented by mild son-
ication and cells were collected by centrifugation at
39,000 × g for 15 minutes. Alkaline extractions were car-
ried out by suspending the cell suspension in ice-cold
distilled water containing the proteinase inhibitors
(0.19 mg/ml PMSF (Sigma-Aldrich, Milan Italy) and
0.7 μg/ml pepstatine (Sigma-Aldrich, Milan Italy) and
then bringing the suspension to pH 12 by adding an ap-
propriate volume of 2.5 N NaOH. After centrifugation
(28,000 × g, 15 min, 4°C), the supernatants were neutral-
ized to pH 7 by the addition of 0.5 M sodium acetate
(pH 5.4) [30].
D,D-dipeptidase and D,D-carboxypeptidase assays
Enzyme activity was assayed by measuring the release of
D-Ala from Nα,Nε-diacetyl-L-Lys-D-Ala-D-Ala, acetyl-L-
Lys-D-Ala-D-Ala and D-Ala-D-Ala by a D-amino acid
oxidase/peroxidase coupled colorimetric assay (i) or by
reaction with a fluorescent reagent (ii). All substrates
were purchased from Sigma-Aldrich. One unit of D,
D-carboxypeptidase activity was defined as the amount
of enzyme that produced 1 μmol of D-Ala per min.
(i) D-Amino acid oxidase/peroxidase assay [17,18].
Reaction mixtures contained 10 mM of the substrate
(Nα,Nε-diacetyl-L-Lys-D-Ala-D-Ala, or acetyl-L-Lys-
D-Ala-D-Ala or D-Ala-D-Ala), 5 mM of the
peroxidase colorimetric substrate 4-aminoantipyrine
(4-AAP, from Sigma-Aldrich, Milan, Italy), 3 U/mL
RgDAAO (D-amino acid oxidase from Rhodotorula
gracilis [18]), 7.5 U/mL horseradish peroxidase (HRP
from Sigma-Aldrich, Milan, Italy), 6 mM phenol in
50 mM 1,3-bis[tris(hydroxymethyl)methylamino]
propane (pH 7.4) in a final volume of 1 mL. At
25°C, 40 μg of recombinant VanYn or the amount of
cell wall alkaline extract correspondent to 50 mg of
cells, or the soluble fraction or the supernatant, was
added to the reaction mixture and the increase in
absorbance (ΔAbs/min) at 510 nm was measured for
the test sample as well as for the control to which
no VanYn was added. A molar extinction coefficient
for chinonemine of 6.58/mM cm was used.
(ii)Fluorimetric o–phthaldialdehyde (OPTA) method
[20]. Reaction mixtures contained 10 mM Nα,Nε-
diacetyl-L-Lys-D-Ala-D-Ala, 40 μg of recombinant
VanYn in 50 mM phosphate buffer (pH 7.0) in a
final volume of 200 μL. After 10 minutes at 25°C,
the reaction was stopped by adding 50 μL of
250 mM HCl followed by 750 μL of water.
Enzymatically released D-Ala was detected by the
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(Sigma-Aldrich, Milan, Italy) to 100 μL of the
reaction mix, followed by incubation at room
temperature for 5 min. 800 μL of water was added
and 200 μL was removed: the fluorescence intensity
was measured (λex = 340 nm; λem = 455 nm) in a
fluorescence microplate reader (Tecan InfiniteW 200
Pro, Milan, Italy). Assays were quantified from a
standard curve prepared with known amounts of
D-Ala.
Circular dichroism measurements
Far-UV CD spectra were recorded with a Jasco J-715
(Jasco Europe, Cremella, Italy) spectropolarimeter in the
195–250 nm wavelength range. Measurements were
made in quartz cuvettes of 1 mm pathlength, employing
protein solutions of 0.1 mg/mL, and were corrected for
buffer contribution. Secondary structure fractions were cal-
culated from deconvolution of the CD spectra using the
program K2D2 (http://www.ogic.ca/projects/k2d2/) [31].
Determination of the biological activity: the minimum
inhibitory concentration (MIC)
Minimal inhibitory concentrations (MICs) of teicoplanin
and vancomycin (Sigma-Aldrich, Milan, Italy) to S. vene-
zuelae containing pIJ86 or pIJ86ΩC-His6-vanYn or
pIJ86ΩN-His6-vanYn was determined in MYM agar
added with 50 μg/mL apramycin and increasing concen-
trations of glycopeptides. The inoculum was 106 cfu/mL
(after mycelium sonication with Sonics Vibracell VCX
130 – power 130 Watt, 230 Volt, 50–60 Hertz, frequency
20 Hz 5 minutes of sonication, 20 seconds for each cycles
with 90% of amplitude), and plates were incubated at 28°C
until colonies appeared. MIC was the lowest concentration
of the antibiotic that inhibits the visible growth of the re-
combinant S. venezuelae strains [32].
Additional files
Additional file 1: Figure S1. SDS-PAGE Analysis of C-His6-VanYn and
N-His6-VanYn from S. venezuelae recombinant strains as in Figure 2 main
text. Analysis of samples corresponding to cellular and extracellular
fractions from cultures of S. venezuelae recombinant strains grown in
YEME for 72 hours. From S. venezuelae pIJ86ΩN-His6-vanYn: extracellular
fraction (lane 1), soluble cell-free fraction (lane 2), insoluble cell-free
fraction (lane 3) and cell wall fraction (lane 4); from S. venezuelae
pIJ86ΩC-His6-vanYn: extracellular fraction (lane 5), soluble cell-free fraction
(lane 6), insoluble cell-free fraction (lane 7) and cell wall fraction (lane 8).
In each lane, samples corresponding to 100 μL of cell culture were
loaded. Std reference protein: C-His6-VanYn from E. coli (5 μg, 25 kDa).
Additional file 2: Figure S2. SDS-PAGE Analysis of C-His6-VanYn from S.
venezuelae recombinant strain growth in 3-L batch fermentor as in
Figure 3 main text. Crude extracts of cell samples collected at different
times of fermentation: 18 (lane 1), 24 (lane 2), 48 (lane 3), 72 (lane 4), 96
(lane 5), 120 (lane 6), 144 (lane 7), 168 (lane 8) hours. In each lane,
samples corresponding to 100 μL of cell culture were loaded. Std
reference protein: C-His6-VanYn from E. coli (5 μg, 25 kDa).Competing interests
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